Company: SHPH
Filing Date: 2025-02-13
Form Type: S-1
Source: 0001493152-25-006202
Chunk: 243

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-13
Form: S-1
Chunk 243
---
) of the Securities Act. Boustead Securities LLC acted as placement agent and received warrants to purchase 5,000 shares of common stock exercisable at $2.50 per share (625 shares at $20.00 per share on a post -reverse split basis), equal to 10% of the value of the note offering, and $12,500 in cash compensation.

In
October 2024, the Company completed two closing in an up to $1.3 million 5% original issue discount (“OID”) senior
secured convertible note warrant offering, pursuant to which the Company issued a total of $831,579 notes and warrants to purchase
329,964 shares of common stock, exercisable at a weighted-average price of $1.42 per share. The notes bear interest at the rate of
14.5% per annum, with the interest payable quarterly in cash, mature one year after the date of issuance, are redeemable at any time
by the Company at a 107% premium to the principal value of the notes and, three months after issuance, can be converted at any time
by the holder at a 110% premium to the principal value of the note. Of the above investment amount, the Company’s CEO
purchased $250,000 of notes and warrants in the October 2024 Bridge Offering.

| II-1 |

| ITEM 
 16.  | EXHIBITS |

| Exhibit 
 No.     |     | Description                                                                                                                                                                                             |
| 1.1*    |     | Form                                                                                                                                                                                                    
 of Underwriting Agreement                                                                                                                                                                               |
| 3.1     |     | Amended                                                                                                                                                                                                 
 and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1 (File                                                                     
 No. 333-265429) filed on June 3, 2022).                                                                                                                                                                 |
| 3.2     |     | Certificate                                                                                                                                                                                             
 of Amendment to Amended and Restated Certificate of Incorporation, effective March 30, 2022 (incorporated by reference to Exhibit                                                                       
 3.2 to the Registration Statement on Form S-1 (File No. 333-265429) filed on June 3, 2022).                                                                                                             |
| 3.3     |     | Amended                                                                                                                                                                                                 
 and Restated Certificate of Designation for Series A Convertible Preferred Stock, effective April 6, 2022 (inc